Meeting NewsVideo

VIDEO: MicroPulse technology reduces IOP in wide range of glaucomatous eyes

SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Shan Lin, MD, talks about a study he and colleagues at UCSF have initiated, using Iridex's MicroPulse laser technology in transscleral cyclophotocoagulation in patients with a range of mild to refractory glaucoma. The technology has so far successfully lowered IOP 20% or more in 68% of eyes treated, he said.

SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Shan Lin, MD, talks about a study he and colleagues at UCSF have initiated, using Iridex's MicroPulse laser technology in transscleral cyclophotocoagulation in patients with a range of mild to refractory glaucoma. The technology has so far successfully lowered IOP 20% or more in 68% of eyes treated, he said.

    See more from Glaucoma 360 New Horizons Forum